the aid library

LIST OPTIONS

Filter

2476

Sort by:

Direction:

Download (776)

View PDF (1519)

Guide national pour la prise en charge et le soutien alimentaire et nutrionnels des personnes vivant avec le VIH en Haiti
recommended

Ministère de la Santé Publique et de la Population, Haiti Fanta project (2010) CC

FANTA provided technical support to Haiti’s Ministry of Public Health and Population for the development of national guidelines and an accompanying flipchart, which provide practical solutions to nutrition problems for people living with HIV, as well as guidance on nutritionally managing the sympt... more

Download (139)

View PDF (224)

Women’s Mental Health: Promoting a Gendered Approach to Policy and Service Provision

The Women´s Health Council The Women´s Health Council (2007) CC

The mission of the Women’s Health Council is to inform and influence the development of health policy to ensure the maximum health and social gain for women in Ireland. Its membership is representative of a wide range of expertise and interest in women’s health. The Women’s Health Council ... more

Download (195)

View PDF (382)

Noncommunicable diseases in the Region of the Americas: facts and figures

Pan American Health Organization (PAHO) (2019) C_WHO

This booklet presents data on NCD mortality and prevalence of NCD risk factors, by country, for the Region of the Americas. The focus is on the 5 x 5 NCD agenda which includes the main NCDs (cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases), and mental health (suicide); as... more

Download (657)

View PDF (1878)

Let's talk TB: a free, online book for primary care providers

Madhukar Pai GP clinics (2018) CC

The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate... more

Download (294)

View PDF (363)

Global action plan on HIV drug resistance 2017–2021

World Health Organization (WHO) (2017) C_WHO

The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ... more

Download (1009)

View PDF (508)

Handbook for a School-based Risk Reduction Initiative

International Federation of Red Cross and Red Crescent Societies (IFRC) (2015) C1

This handbook presents basic content and tips for implementing a school-based risk reduction programme. It is organised into five modules: its importance; approach and process; activities to benefit children up to five years old; activities for students aged 5–17; and activities for young people a... more

Download (477)

View PDF (876)

State of Health in the WHO African Region
recommended

World Health Organization WHO, Regional Office African Region (2018) C_WHO

This report is not a country scorecard. Rather, its purpose is to act as a compass to guide progress towards health in the SDGs. There has been a significant improvement in the state of health in the region with healthy life expectancy - time spent in full health - in the region increasing from 50... more

Download (200)

View PDF (289)

The 2014 Myanmar Population and Housing Census: Thematic Report on Mortality

The Republic of the Union of Myanmar (2016) C1

Census Report Volume 4-B
In the 2014 Census, early-age mortality was measured from the responses to two simple retrospective questions on childbearing addressed to ever-married women aged 15 and over. These questions referred to how many live children they had ever given birth to, and how many ... more

Download (156)

View PDF (165)

2019 Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline
recommended

World Health Organization WHO (2019) C_WHO

Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions. Gr... more

Download (261)

View PDF (437)

WHO recommendations on adolescent sexual and reproductive health and rights

World Health Organization WHO (2018) C_WHO

This document provides an overview of sexual and reproductive health and rights issues that may be important for the human rights, health and well-being of adolescents (aged 10–19 years) and the relevant World Health Organization (WHO) guidelines on how to address them in an easilyaccessible, user... more

Download (126)

View PDF (128)

Ongoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews. Rapid Review

Pan American Health Organisation PAHO (2020) C_WHO

As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I... more

Download (183)

View PDF (115)

Implementation Framework & Clinical Guidance for Viral Hepatitis Prevention & Treatment 2019

Ministry of Health, Zambia (2020) CC

The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ... more

Download (124)

View PDF (150)

Pertussis Vaccine-Preventable Diseases Surveillance Standards

World Health Organization WHO (2018) C_WHO

The objectives of pertussis surveillance are to:hmonitor disease burden and the impact of the pertussis vaccination programme, with a special focus on understanding the morbidity and mortality in children < 5 years of agehgenerate data to inform vaccine schedule and delivery strategy decisions to op... more

Download (187)

View PDF (278)

Bearing the brunt: The impact of COVID-19 on older people in low- and middle-income countries – insights from 2020

HelpAge (2021) C1

The report shows that older people are not getting the healthcare treatments they desperately need. The COVID-19 response has disrupted services for non-communicable diseases such as cancer and diabetes, communicable diseases such as malaria, and much-needed services for mental health. Combined with... more

Download (86)

View PDF (333)

Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation–Lancet Commission on planetary health | Sustainable Development Goals - Resource Centre

Whitmee S., Haines A. et al. (2015) C2

By almost any measure, human health is better now than at any time in history. Life expectancy has soared from 47 years in 1950–1955, to 69 years in 2005–2010, and death rates in children younger than 5 years of age have decreased substantially, from 214 per thousand live births in 1950–1955, ... more

Download (179)

View PDF (216)

Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended

World Health Organization WHO (2022) C_WHO

This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19. In this edition, new information includes updated mask re... more

Download (99)

View PDF (999)

Elimination of human rabies in Goa, India through an integrated One Health approach

Gibson, A.; Yale, G.; Corfmat, J.; et al. nature communications (2022) CC

Rabies is a devastating and societally important zoonotic disease, which is transmitted principally to humans through the bite of infected dogs. This acute, progressive viral encephalitis has the highest case fatality of any infectious disease and kills tens of thousands of people annually, with chi... more

Download (111)

View PDF (121)

Ending disease in Africa: vision, strategies and special initiatives, 2023-2030

World Health Organisation (WHO) (2023) C_WHO

While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa... more

Download (239)

View PDF (322)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (17)

View PDF (11)

Understanding and controlling asthma in Latin America: A review of recent research informed by the SCAALA programme

Cooper, P. J.; Figueiredo, C. A.; Rodriguez, A.; et al. (2023) CC2

Asthma is the most common chronic respiratory disease (CRD) worldwide and is estimated to affect 262 million causing significant mortality and morbidity, and has emerged as an important public health problem in many Latin American (LA) countries over the last 30 or so years. LA is a highly diverse r... more

Guide national pour la prise en charge et le soutien alimentaire et nutrionnels des personnes vivant avec le VIH en Haiti recommended

State of Health in the WHO African Region recommended

2019 Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline recommended

Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline recommended

Guide national pour la prise en charge et le soutien alimentaire et nutrionnels des personnes vivant avec le VIH en Haiti
recommended

State of Health in the WHO African Region
recommended

2019 Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline
recommended

Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended